Tag: COVID-19

Who is most at risk for long COVID-19?

Editor's Note In this study, Japanese researchers found that COVID-19 severity is not a risk factor for long COVID-19, but older age is. Analysis of responses to a questionnaire survey from 127 recovered patients found that: 52% had sequelae at a median of 29 days from COVID-19 onset, and prevalence…

Read More

By: Judy Mathias
May 19, 2022
Share

Session: Leadership roundtable panel

Editor's Note In this wrap-up roundtable discussion, members of the conference planning committee Hazel Boyd, MBA, clinical operations manager at Boston Children’s Hospital; Sheila Stein, MSN, FNP, CNS, CNOR, robotics coordinator at Cayuga Medical Center; and Denise Waslo, MSN, RN, CNOR, CSSM, NE-BC, director of perioperative services at Long Island…

Read More

By: Tarsilla Moura
May 18, 2022
Share

Effect of ‘serenity lounges’ on nurse stress, burnout during COVID-19

Editor's Note This study by nurse researchers from Cedars-Sinai Medical Center in Los Angeles evaluates the effect of “serenity lounges” (ie, dedicated rooms where nurses can take breaks to relax and rejuvenate) and massage chairs on nurse anxiety, stress, and burnout, during the COVID-19 pandemic. The researchers analyzed 67 paired…

Read More

By: Judy Mathias
May 12, 2022
Share

The Joint Commission asks HCWs to remain masked while interacting with surveyors, reviewers

Editor's Note The Joint Commission, on May 11, announced that surveyors and reviewers will remain masked, adhere to social distancing, and follow other Centers for Disease Control and Prevention guidelines while onsite at an organization. The Joint Commission asks that healthcare workers (HCWs) and organization staff also remain masked while…

Read More

By: Judy Mathias
May 12, 2022
Share

COVID-19 linked to ICU admissions of children, adolescents with self-harm

Editor's Note This Australian study finds that the COVID-19 pandemic was associated with a significant increase in ICU admissions of children and adolescents with deliberate self-harm. Of 813 study patients aged 12 to 17 years, 230 (15.2%) were admitted during the first 15 months of the COVID-19 pandemic. Among the…

Read More

By: Judy Mathias
May 12, 2022
Share

Downstream effects of COVID-19 generated surgical backlog

Editor's Note Delayed elective surgical procedures because of COVID-19 resulted in more emergency department (ED) visits and the need for urgent interventions for gallstone disease but not inguinal hernias, this Canadian study finds. Researchers identified 74,709 elective cholecystectomies and 60,038 elective inguinal hernia repairs. During COVID-19 first and second waves…

Read More

By: Judy Mathias
May 11, 2022
Share

Omicron BA.2.12.1 subvariant gaining a foothold

Editor's Note Though new COVID-19 cases linked to the Omicron BA.2 subvariant are dropping, Omicron’s more infectious subvariant BA2.12.1 is beginning to gain a foothold in the US, the May 10 Becker’s Hospital Review reports. Omicron BA2.12.1 now accounts for nearly 43% of new cases as of May 7, compared…

Read More

By: Judy Mathias
May 11, 2022
Share

FDA: Class I recall of certain Accula SARS-CoV-2 Tests

Editor's Note The Food and Drug Administration (FDA) on May 9 identified the recall by Mesa Biotech, Inc, of certain Accula SARS-CoV-2 Tests as Class I, the most serious. The recall was initiated because certain lots of the PCR test have an increased risk of giving false positive results because…

Read More

By: Judy Mathias
May 11, 2022
Share

Study: Divergent drinking patterns acquired by US adults during COVID-19

Editor's Note In this study from the University of Southern California, Los Angeles, researchers identify distinct demographic subpopulations with diverging drinking trajectories during the first 10 months of the COVID-19 pandemic. A total of 8,130 US adults were surveyed biweekly from March 2020 to January 2021 on their past-week alcohol…

Read More

By: Judy Mathias
May 10, 2022
Share

FDA limits use of J&J COVID-19 vaccine because of TTS risk

Editor's Note The Food and Drug Administration (FDA) on May 5 announced that it has limited the authorized use of Johnson & Johnson’s Janssen COVID-19 vaccine to those 18 years of age and older for whom other COVID-19 vaccines are not accessible or clinically appropriate and to those who would…

Read More

By: Judy Mathias
May 10, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat